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Abstract
Introduction: In vitro studies indicate that vaspin may act as a regulator of bone metabolism. The aim of the study was to evaluate the 
relationship between vaspin and bone metabolism in girls with anorexia nervosa (AN), as well as the potential involvement of OPG and 
RANKL in this relationship.
Material and methods: Serum vaspin, OC, CTx, OPG, and sRANKL were determined by ELISA in 50 girls with AN and in 30 healthy 
controls aged 13 to 17 years. 
Results: Girls with AN exhibited significant reduction in body weight, BMI, and Cole index as well as a significant increase in serum 
level of vaspin compared to healthy participants. These changes were associated with a significant decrease in serum OC and CTx levels 
and a significant increase in OPG and sRANKL, while the OPG/sRANKL ratio was significantly decreased. BMI and Cole index corre-
lated negatively and significantly with CTx levels in the control group (C), girls with AN, and all study participants (C+AN). Girls with 
AN showed a significant negative correlation between BMI, the Cole index, and OPG levels. The combination group (C+AN) showed 
a significant positive correlation between BMI, Cole index, and the OPG/sRANKL ratio. In this group of girls vaspin levels correlated posi-
tively and significantly with sRANKL and negatively with body weight, BMI, Cole index, and OPG/sRANKL ratio. Girls with AN showed 
a significant negative correlation between vaspin levels and the OPG/sRANKL ratio. 
Conclusions: Undernourishment and associated deficit of adipose tissue may result in inadequate vaspin production and bone metabolism 
disorders in girls with AN. Vaspin acts as a coordinator of the dynamic balance between bone formation and resorption processes; its 
action is affected by the cytokines of the RANKL/RANK/OPG system. Changes in the relationships between vaspin, bone markers, OPG, 
and RANKL might contribute to the development of osteoporosis in girls with AN. (Endokrynol Pol 2016; 67 (6): 599–606)
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Streszczenie
Wstęp: Badania in vitro sugerują, że waspina może mieć znaczenie w regulacji metabolizmu kostnego. Celem pracy była ocena związku 
między waspiną a metabolizmem kostnym u dziewcząt z jadłowstrętem psychicznym (AN) z uwzględnieniem ewentualnego udziału 
OPG i RANKL w mechanizmie powiązań między nimi. 
Materiał i metody: U 50 dziewcząt z AN i 30 zdrowych w wieku 13–17 lat oceniono stężenia waspiny, OC, CTx, OPG i sRANKL w suro-
wicy metodą ELISA. 
Wyniki: U dziewcząt z AN wykazano istotne zmniejszenie masy ciała, BMI i wskaźnika Cole’a oraz znamienny wzrost stężenia wa-
spiny w surowicy w porównaniu z grupą dziewcząt zdrowych. Zmianom tym towarzyszyła znamienna supresja stężeń OC, CTx oraz 
wzrost stężeń OPG i sRANKL w surowicy przy istotnie obniżonych wartościach wskaźnika OPG/sRANKL. Wartości wskaźników BMI 
i Cole’a korelowały istotnie i ujemnie ze stężeniami CTx w grupie kontrolnej (C), u dziewcząt z AN i u wszystkich dziewcząt łącznie (grupa 
C+AN) i OPG (u dziewcząt z AN). Istotną i dodatnią korelację wykazano między wartościami wskaźników BMI i Cole’a a wartościami 
wskaźnika OPG/sRANKL w grupie C+AN. W grupie tej stężenia waspiny korelowały istotnie i dodatnio ze stężeniami sRANKL, a ujemnie 
z wartościami masy ciała, BMI, wskaźnika Cole’a i wskaźnika OPG/sRANKL. Ujemną i znamienną korelację między stężeniami waspiny 
a wartościami wskaźnika OPG/sRANKL zanotowano u dziewcząt z AN. 
Wnioski: Niedożywienie i związany z nim deficyt tkanki tłuszczowej mogą indukować nieprawidłowości w produkcji waspiny i metabo-
lizmie kostnym u dziewcząt z AN. Waspina wpływa na dynamiczną równowagę między procesami tworzenia i resorpcji tkanki kostnej, 
a ważną rolę w mechanizmie tego oddziaływania odgrywają cytokiny systemu RANKL/RANK/OPG. Zaburzenia w powiązaniach między 
waspiną, markerami kostnymi oraz OPG i RANKL mogą wpływać na rozwój osteoporozy u dziewcząt z jadłowstrętem psychicznym. 
(Endokrynol Pol 2016; 67 (6): 599–606)
Słowa kluczowe: jadłowstręt psychiczny; dziewczęta; waspina; metabolizm kostny; OPG; sRANKL; wskaźnik OPG/sRANKL
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Introduction
Vaspin, a visceral adipose tissue-derived serine protein-
ase inhibitor, was isolated in 2005 from visceral adipose 
tissues of Otsuka Long-Evans Tokushima Fatty (OLETF) 
rat, an animal model of abdominal obesity and type 2 
diabetes mellitus [1, 2]. Animal studies revealed that 
vaspin improved glucose tolerance, increased insulin 
sensitivity, reduced food intake, lowered blood glucose, 
and exhibited anti-inflammatory action [2–4]. Vaspin 
expression was almost undetectable in the diabetes-
resistant lean rats (LETO) in comparison to OLETF 
rats. Experimental studies of Gonzales et al. [5] showed 
that vaspin gene expression in rat white adipose tis-
sue was the lowest after fasting; leptin administration 
and chronic treatment with metformin increased its 
expression. Decreased levels of growth hormone (GH) 
and thyroid hormones also suppressed vaspin expres-
sion [5]. 
In humans, vaspin expression was demonstrated 
in subcutaneous and visceral adipose tissue of obese 
individuals with normal glucose tolerance [6]. Vaspin 
expression in visceral adipose tissue increased along 
with an increase in body mass index (BMI), body fat 
percentage and glucose concentration in hour 2 of an 
oral glucose tolerance test [6,7]. Subcutaneous vaspin 
expression was positively correlated with waist-to-hip 
ratio (WHR) and fasting serum insulin concentration 
[8]. In the normal glucose-tolerant group, vaspin serum 
concentration was higher in women compared to men, 
and it correlated positively with body fat mass and 
BMI [9]. Elevated vaspin serum concentrations were 
associated with obesity and impaired glucose toler-
ance; however, study participants with diabetes did 
not exhibit such correlations [10, 11]. Some researchers 
believe that elevation of serum vaspin may arise as 
a compensatory mechanism for obesity and insulin 
resistance [8, 12–14]. El-Mesalamy et al. [15] demon-
strated vaspin elevation in non-obese and obese type 
2 diabetes patients compared with the control subjects. 
Women with poor glycaemic control (HbA1c > 7%) had 
higher vaspin levels than those with HbA1c < 7% [14]. 
Serum vaspin concentrations are related to physical 
activity; the concentrations are lower in normal-weight 
and regularly exercising individuals but tend to increase 
in obese people on weight loss regimens combined with 
physical exercise programs [10]. Handisuraya et al. [16] 
observed that bariatric surgery-induced weight loss 
resulted in a reduction of serum vaspin that correlated 
significantly with the reduction of circulating leptin, in-
sulin, and C-peptide levels and with the amelioration of 
insulin sensitivity. In obese children, vaspin levels were 
significantly higher compared to their normal-weight 
peers [17, 18]. Vaspin levels were positively correlated 
with triglycerides, HOMA-IR, and BMI, while their 
correlation with adiponectin levels was negative. The 
body fat percentage was found to be the strongest pre-
dictor of visceral vaspin, and insulin sensitivity seems 
to be the strongest determinant of subcutaneous vaspin 
expression [17]. On the other hand, Körner et al. [19] 
revealed that vaspin concentration was lower in obese 
girls compared to lean controls; also, no correlation was 
found between serum vaspin and BMI. It is generally 
believed that differences in vaspin levels between obese 
individuals (children, adolescents, adults) are related to 
gender, age, physical activity, and hormone metabolism. 
Few researchers have studied vaspin levels in in-
dividuals with body mass deficits [20, 21]. Bergmann 
and Sypniewska [20] found an approximately 50% 
decrease in vaspin levels in their study participants 
with BMI < 25 kg/m2 compared to overweight subjects 
(BMI 25–29.9 kg/m2). Vehapoglu et al. [21] observed 
that vaspin concentrations were significantly lower in 
underweight prepubertal children (youngest age = 2 
years) compared to the control group. Our preliminary 
investigations revealed vaspin elevation in girls with 
AN aged 13 to 17 years as compared to normal-weight, 
age-matched controls (C) [22]. The combination group 
(C+AN) exhibited a negative correlation between 
vaspin levels and body weight and BMI, suggesting 
that undernourishment might cause abnormal levels 
of vaspin.
The most recent in vitro studies seem to indicate 
that, along with leptin, adiponectin, resistin, visfatin, 
apelin and omentin-1 [23–27], vaspin may regulate 
bone metabolism. Kamio et al. [28] concluded that 
vaspin inhibited RANKL-induced osteoclastogenesis in 
RAW264.7 cells and bone marrow cells. It also attenu-
ated the apoptosis of human osteoblasts [29]. Hence the 
hypothesis that changes in vaspin levels observed in 
girls with AN [22] might play a role in inducing changes 
in bone metabolism found in these patients, the effect of 
which might be mediated by the RANKL/RANK/OPG 
system. Therefore, we designed a study to examine the 
relationship between vaspin and the well-established 
markers of bone metabolism, i.e. osteocalcin (OC) — 
a marker of bone formation, and C-terminal telopep-
tide of type I collagen a 1 chain (CTx) — a marker of 
bone resorption in girls with AN. We also considered 
the role of the cytokines of the RANKL/RANK/OPG 
system, i.e. OPG and sRANKL in this relationship. The 
obtained results might help to gain deeper insight into 
the pathomechanisms of osteoporosis development in 
girls with AN. 
The aim of the study was to evaluate the relationship 
between vaspin and bone metabolism in girls with AN, 
taking into consideration a potential role of OPG and 
RANKL in this relationship. 
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Material and methods
The study group consisted of 50 girls aged 13 to 17 years, 
hospitalised at the Paediatric Endocrinology Division of 
the Paediatric Department in Zabrze, who, following an 
examination by paediatricians and a psychiatrist, were 
diagnosed with AN based on the American Psychiat-
ric Association’s classification and diagnostic tool, i.e. 
a DSM-IV of 1994. The girls with AN underwent all 
tests during the first three days of hospital stay, i.e. prior 
to the launch of therapy. All other somatic or mental 
disorders that might lead to cachexia were ruled out. 
The mean age of the AN patients was 15.02 ± 1.52 
years (Table I). All had secondary amenorrhoea. The 
duration of the disease was 3-60 months. The control 
group consisted of 30 healthy, regularly menstruating 
girls (mean age 15.99 ± 2.19 years) with no endocrine 
or other disorders that could affect bone tissue metabo-
lism; they were all schoolgirls from the city of Zabrze, 
who volunteered to participate in the study. 
Objective assessment included anthropometric 
evaluation such as weight and height measurements. 
Body mass index (BMI; weight/height2 [kg/m2]) and 
the Cole index (CI; weight × height2 × 100 [%]) were 
calculated [23]. The Cole index reflects the nutritional 
status of an individual and encompasses the following 
categories: wasting — < 75%; undernourished — 
75–85%; mildly undernourished — 85–90%; adequately 
nourished — 90–100%; and overnourished — > 110% 
[acc. to 24]. The mean body weight of our AN patients 
was: 39.89 ± 5.401 kg, BMI: 15.61 ± 2.08 kg/m2, and the 
Cole index: 79.88 ± 0.19%. The mean body weight of the 
control participants was: 55.93 ± 7.21 kg, BMI: 20.54 ± 
± 2.12 kg/m2, and the Cole index: 100.18 ± 0.89% (Table I).
On the day of the examination the girls did not 
report any complaints; none of them suffered from 
an acute infection during the preceding month. Blood 
samples for the determination of vaspin, OC, CTx, as 
well as OPG and its soluble ligand sRANKL were col-
lected between 08.00 and 09.00 hours after a 12-hour 
fast. Serum obtained by centrifugation was frozen and 
stored at –75°C until assay. Determinations of vaspin, 
OC, CTx, OPG, and sRANKL concentrations were 
performed using High-Sensitivity Human ELISA kits: 
vaspin (BioVendor Laboratorni medicina a.s., Czech 
Republic), OC (DSL Inc., USA), CTx (Nornic Biosci-
ence Diagnostics A/S, Denmark), OPG, and sRANKL 
(Biomedica, Austria). The respective sensitivity and 
intra- and interassay errors were: 0.01 ng/mL, 7.6% and 
7.7% for vaspin; 0.05 ng/mL, 5.8 and 7.3% for OC; 0.08 
nmol/L, 5.2 and 6.7% for CTx; 0.14 pmol/L, 7 and 7.5% 
for OPG; 0.04 pmol/L, 5 and 7% for sRANKL. 
The database was prepared using Excel 2000 (Mi-
crosoft Corporation). Statistical analysis was carried out 
with Statistica 10 for Windows (StatSoft Inc., USA). All 
data were tested for normality of distribution with the 
Shapiro-Wilk algorithm. The Student t-test was used 
to determine the significance of intergroup differences 
(normal distribution of variables). In the case of non-
normal distribution, the significance was tested using 
the Mann-Whitney U test. The relationships between 
the BMI, Cole index and OC, CTx, OPG, sRANKL, and 
the the OPG/sRANKL ratio as well as between vaspin 
and age, height, body weight, BMI, Cole index, OC, 
CTx, OPG, sRANKL and the OPG/sRANKL ratio in con-
trol participants (C), girls with AN, and the combination 
group of C+AN were analysed using the Spearman’s 
ranked correlation test. Statistical significance was set 
at p ≤ 0.05.
The study was approved by the Bioethics Com-
mittee of the Silesian Medical University in Katowice 
(KNW/0022/KB1/105/09). Informed consent to partici-
pate in the study was obtained from the patients, their 
parents, or guardians. 
Table I. Mean values of age, height, body weight, body mass 
index (BMI),  the Cole index (CI), mean serum levels of vaspin, 
osteocalcin (OC), C-terminal telopeptide of type I collagen a 1 
chain (CTx), osteoprotegerin (OPG), soluble receptor activator 
of nuclear factor-kB ligand (sRANKL), and mean values of 
the OPG/sRANKL ratio in girls with anorexia nervosa and 
in the control group
Tabela I. Średni wiek, wzrost, masa ciała, wskaźnik masy 
ciała (BMI), wskaźnik Cole’a (CI), średnie stężenia waspiny, 
osteokalcyny (OC), C-terminalnego usieciowanego telopeptydu 
łańcucha a1 kolagenu typu I (CTx), osteoprotegeryny (OPG), 
rozpuszczalnego ligandu receptora aktywatora czynnika 
jądrowego-kB (sRANKL) oraz wartości wskaźnika OPG/ 
/sRANKL w grupie kontrolnej i u dziewcząt z jadłowstrętem 
psychicznym
Variables Groups
Control group  
(n = 30)
Anorexia nervosa 
(n = 50)
Age (years) 15.99 ± 2.19 15.02 ± 1.57 
Height [m]  1.64 ± 0.09 1.61 ± 0.08
Body weight [kg] 55.93 ± 7.21 39.89 ± 5.41*
BMI [kg/m2] 20.54 ± 2.12 15.61 ± 2.08*
CI (%) 100.18 ± 0.89 79.88 ± 0.19*
Vaspin [ng/mL]  0.42 ± 0.08  0.58 ± 0.08*
OC [μmol/L]  4.34 ± 1.05  3.52 ± 1.59*
CTx [nmol/L]  5.92 ± 1.72  3.55 ± 2.50*
OPG [pmol/L]  3.40 ± 0.64  4.69 ± 0.80*
sRANKL [pmol/L]  0.51 ± 0.17  0.62 ± 0.28*
OPG/sRANKL ratio  12.38 ± 4.65  8.86 ± 2.86*
 *p £ 0.05 vs. control group
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Results
The mean body weight, BMI, and the Cole index were 
significantly lower in girls with AN compared to healthy 
controls, while the mean serum vaspin was significantly 
higher. All these changes were associated with marked 
suppression of the mean serum OC and CTx and an 
increase in the mean serum OPG and sRANKL, while 
the mean value of the OPG/sRANKL ratio was decreased 
compared to normal-weight controls (Table I).
In all groups, i.e. the control participants, girls with 
AN, and the combination C+AN group, the BMI and 
Cole indexes correlated negatively and significantly 
with CTx. Girls with AN also exhibited a negative and 
significant correlation between the BMI and Cole in-
dexes and OPG. The C+AN group showed a positive 
and significant correlation between the BMI and Cole 
indexes and the OPG/sRANKL ratio (Table II). 
In the combination group (C+AN), vaspin levels 
were positively and significantly correlated with 
sRANKL, while their correlation with body weight, the 
BMI, and Cole indexes and the OPG/sRANKL ratio was 
negative. Girls with AN had a negative and significant 
correlation between serum vaspin levels and the OPG/ 
/sRANKL ratio values (Table III). 
Discussion
In our previous [22] and present studies, we found an 
increase in serum vaspin in girls with AN compared to 
normal-weight healthy controls with normal BMI range 
(group C). We also observed a negative and significant 
correlation between body weight, BMI, and vaspin 
levels in all study participants (group C+AN), i.e. in 
the group that exhibited considerable body weight dif-
ferences. Additionally, the results of the present study 
revealed a negative and significant correlation between 
the Cole index and serum vaspin in this group. These 
findings indicate that undernourishment and associ-
ated adipose tissue deficit may result in inadequate 
vaspin production in girls with AN.
Few researchers studied circulating vaspin levels in 
underweight persons, but some observed a significant 
decrease in serum vaspin in individuals with BMI < 25 kg/ 
/m2 compared to overweight participants [20]. Mean 
vaspin levels were significantly lower in underweight 
prepubertal children with thinness grades of 1, 2, and 
3 and body weights < 90% of ideal body weight due 
to loss of appetite and less frequent hunger episodes 
compared to the control group [21]. The authors 
concluded that in underweight children, decreased 
vaspin levels should be considered in the aetiology of 
anorexia. It was also shown that although circulating 
vaspin was lower in slim and regularly exercising study 
subjects than in untrained individuals [10, 32], its con-
centrations increased in obese people on weight loss 
regimens combined with physical exercise programs 
[10]. This paradox has been accounted for by the fact 
that the serum vaspin level is differentially regulated in 
the non-active resting state and after exercise. Dietary 
Table II. Correlation between body mass index (BMI), Cole index (CI) and osteocalcin (OC), C-terminal telopeptide of type I 
collagen a1 chain (CTx), osteoprotegerin (OPG), soluble receptor activator of nuclear factor-kB ligand (sRANKL) levels, and 
the OPG/sRANKL ratio in the control group (C), in girls with anorexia nervosa (AN), and in all girls (C+AN)
Tabela II. Tabela II. Korelacja między wartościami wskaźnika masy ciała (BMI) i wskaźnika Cole’a (CI) a osteokalcyną (OC), 
C-terminalnym usieciowanym telopeptydem łańcucha a1 kloagenu typu I (CTx), osteoprotegeryną (OPG), rozpuszczalnym 
ligandem receptora aktywatora czynnika jądrowego-kB (sRANKL) i wartościami wskaźnika OPG/sRANKL w grupie kontrolnej 
(C), u dziewcząt z jadłowstrętem psychicznyn (AN), i u wszystkich dziewcząt łącznie (C + AN) 
Variables Values of correlation coefficients
C (n = 30) AN (n = 50) C+AN (n = 80)
BMI [kg/m2] OC [μmol/L]  –0.322  0.211 –0.202
CTx [nmol/L]  –0.476* –0.380*  –0.345*
OPG [pmol/L] –0.079 –0.270* –0.163
sRANKL [pmol/L]  0.058 0.150 –0.066
OPG/sRANKL ratio  0.060 0.146  0.250*
CI (%) OC [μmol/L] –0.299 0.199 –0.150
CTx [nmol/L]  –0.488*  –0.419*  –0.334*
OPG [pmol/L] –0.190  –0.209* –0.098
sRANKL [pmol/L] –0.051  0.169 –0.070
OPG/sRANKL ratio  0.082  0.160  0.257*
*p £ 0.05 — statistically significant values of correlation coefficients
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interventions [33–35] and bariatric surgery [16, 36] used 
in obese people usually resulted in weight loss. It has 
been speculated that differences in vaspin concentra-
tions seen in underweight individuals are associated 
with gender, age, physical activity, and interference of 
several endogenous factors, mainly hormones. 
Studies carried out by Gonzales et al. [5] revealed 
that white adipose tissue (WAT) vaspin mRNA lev-
els were down-regulated in hyperthyroid rats and 
significantly increased in hypothyroid animals in 
comparison to euthyroid ones. Hence the final conclu-
sion that thyroid status plays an important role in the 
regulation of vaspin in rats. Abnormal levels of vaspin 
in hypo- and/or hyperthyroid patients have been re-
ported with controversial results. Cinar et al. [37, 38] 
showed that vaspin levels were not correlated with 
TSH levels in hypothyroid patients before treatment 
and after establishment of euthyroidism. On this basis 
the authors concluded that vaspin might be differently 
regulated in humans and rodents. Although it was not 
meant to investigate the relationship between vaspin 
and thyroid function in humans, one study examined 
the relation between TSH and vaspin levels before 
and after weight loss by bariatric surgery (RYGB) [16]. 
Handisuraya et al. [16] showed that RYGB induced 
a significant reduction in circulating TSH levels, which 
correlated positively with changes in vaspin levels. The 
Gonzales et al. [5] studies also revealed that WAT vaspin 
mRNA levels were down-regulated in GH-deficient rats 
compared to control animals, suggesting that vaspin 
may be particularly sensitive to the influence of GH. 
The above-mentioned experimental and clinical data 
suggested that somatotroph cell function can play 
a role in vaspin regulation. Thus, it could be hypoth-
esised that, in girls with AN, circulating vaspin levels 
might be influenced by changes in GH and thyroid 
hormone concentrations. Persistent fasting results in 
disturbances in somatoliberin and somatostatin secre-
tion in AN patients. Despite elevated GH levels, insulin-
like growth factor I (IGF-I) is reduced, which leads to an 
acquired GH-resistant state [39–42]. Patients with AN 
exhibit high GH concentrations both at baseline and 
after somatoliberin or thyreoliberin stimulation, while 
somatostatin levels remain low. On the other hand, 
a tendency towards suppression of the hypothalamic-
pituitary-thyroid axis was also found [24, 41, 43, 44]. 
A decrease of 5’-deiodinase activity compromises con-
version of thyroxine (T4) to 3,5,3’-triiodothyronine (T3), 
giving rise to the hormonally inactive 3,3’,5’-triiodo-
thyronine, i.e. reverse T3 (rT3) [24, 42, 44]. Experimental 
studies in rats also demonstrated that vaspin concen-
trations decreased after fasting and were partially re-
covered after leptin treatment [5], results which were 
then confirmed by human studies [7]. On the other 
hand, vaspin levels were negatively correlated with 
adiponectin [7]. Hence, changes in leptin and adiponec-
Table III. Correlation between vaspin levels and age, height, body weight, body mass index (BMI), the Cole index (CI), as 
well as osteocalcin (OC), C-terminal telopeptide of type I collagen a 1 chain (CTx), osteoprotegerin (OPG), soluble receptor 
activator of nuclear factor-kB ligand (sRANKL) levels, and the OPG/sRANKL ratio in the control group (C), in girls with 
anorexia nervosa (AN), and in all girls (C+AN)
Tabela III. Korelacja między stężeniami waspiny a wiekiem, wzrostem, masą ciała, wskaźnikiem masy ciała (BMI), 
wskaźnikiem Cole’a (CI) oraz stężeniami osteokalcyny (OC), C-terminalnego usieciowanego telopeptydu łańcucha a 1 kolagenu 
typu I (CTx), osteoprotegeryną (OPG), rozpuszczalnym ligandem receptora aktywatora czynnika jądrowego-kB (sRANKL) 
oraz wartościami wskaźnika OPG/sRANKL w grupie kontrolnej (C), u dziewcząt z jadłowstrętem psychicznym (AN), 
i u wszystkich dziewcząt łącznie (C+AN) 
Variables Values of correlation coefficients
C (n = 30) AN (n = 50) C+AN (n = 80)
Vaspin [ng/mL]
Age (years) –0.084 0.185 0.054
Height [m]  0.236 0.073 0.207
Body weight [kg] –0.077  –0.153  –0.204*
BMI [kg/m2] –0.264  –0.136  –0.298*
CI (%)  –0.021 –0.160  –0.268*
OC [μmol/L]  0.018 –0.049 –0.120
CTx [nmol/L]  0.138  0.299  0.123
OPG [pmol/L] –0.138  –0.046  –0.085
sRANKL [pmol/L]  0.142  0.133  0.250*
OPG/sRANKL ratio  0.301  –0.298*  –0.231*
 *p £ 0.05 — statistically significant values of correlation coefficients
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tin concentrations observed in girls with AN [26, 35, 
45] might possibly affect serum vaspin concentrations. 
The most recent studies, especially in vitro studies, 
indicated that, along with leptin, adiponectin, resistin, 
visfatin, apelin and omentin-1 [24–27], vaspin may 
also act as a bone metabolism regulator. Kamio et al. 
[28] found that vaspin inhibited RANKL-induced os-
teoclastogenesis in RAW264.7 cells and bone marrow 
cells (BMCs) as well as the RANKL-induced expression 
of nuclear factor of activated T cells c1 (NFATc1) in 
RAW264.7 cells and BMCs. Vaspin also inhibited the 
RANKL-induced upregulation of matrix metallopro-
teinase-9 and cathepsin K in RAW264.7 cells. Hence 
the final conclusion that vaspin downregulates os-
teoclastogenesis in part by inhibiting expression of the 
transcription factor NFATc1 [28]. Vaspin also attenuated 
the apoptosis of human osteoblasts [29]. Western blot 
analysis indicates that, depending on the dose, vaspin 
upregulates the expression of anti-apoptotic gene Bcl-2 
and downregulates the expression of BAX, which plays 
a crucial role in apoptosis induction. Vaspin stimulates 
the phosphorylation of ERK; hence, pretreatment of hu-
man osteoblasts with ERK inhibitor PD98059 blocks the 
ERK pathway. However, vaspin does not stimulate the 
phosphorylation of p38, JNK, or Akt. It attenuates the 
apoptosis of human osteoblasts by activating the MAPK/ 
/ERK signalling; this suggests that vaspin might be in-
volved in bone metabolism regulation (via its protective 
effect on osteoblasts). Based on the in vitro results, it is 
likely that changes in vaspin concentrations observed 
in girls with AN might, along with changes in other 
adipose tissue hormones [26, 27], play a role in bone 
metabolism disturbances with the RANKL/RANK/OPG 
system being involved also. To our knowledge there 
have been no studies on the relationship between cir-
culating vaspin levels and bone metabolism in girls with 
AN with the consideration of the role of the RANKL/ 
/RANK/OPG system’s cytokines in this relationship. 
Our investigations have shown that undernourish-
ment and extreme weight loss may not only lead to 
abnormal levels of vaspin but also to bone metabolism 
disturbances. Reduction in body weight, BMI, the Cole 
index, and serum vaspin elevation in girls with AN were 
associated with significant suppression of OC and CTx 
and an increase in serum OPG and sRANKL, while 
the OPG/sRANKL ratio was significantly decreased. In 
all study groups (C, AN, and C+A) the BMI and Cole 
indexes were negatively and significantly correlated 
with CTx concentrations. In girls with AN, the BMI and 
Cole indexes also correlated negatively and significantly 
with OPG concentrations. In the combination group, 
i.e. C+AN, there was a positive and significant correla-
tion between the BMI and Cole indexes and the OPG/ 
/sRANKL ratio as well as between serum vaspin and 
sRANKL. Vaspin concentrations were negatively and 
significantly correlated with the OPG/sRANKL ratio 
in girls with AN and the combination group (C+AN). 
Differences in results from in vivo and in vitro stud-
ies on the relationships between bone metabolism, 
RANKL/RANK/OPG system cytokines, and vaspin 
may be associated with the interference of several 
endogenous factors, mainly hormones (i.e. oestrogens, 
glucocorticoids, parathyroid hormone, and vitamin D), 
adipose tissue hormones other than vaspin, and cy-
tokines, whose concentrations are altered in girls with 
AN [25–27, 41, 43, 44, 46–52]. These factors may have 
a direct or RANKL/RANK/OPG system-mediated effect 
on bone metabolism. However, an indirect influence of 
vaspin on bone metabolism should also be taken into 
consideration, e.g. via its effect on the secretion of sev-
eral osteotropic factors including leptin, adiponectin, 
or proinflammatory cytokines. 
Vaspin was shown to inhibit adiponectin and stimu-
late leptin secretion in the adipose tissue [7]. Hence, 
it might be hypothesised that the effect of vaspin on 
bone metabolism could be partly mediated via these 
adipokines. It is well known that osteoclastogenesis is 
increased by adiponectin via the RANKL/OPG mecha-
nism [53, 54]. In vitro studies revealed that adiponectin 
stimulated RANKL and inhibited OPG expression 
in human osteoblasts through the MAPK signalling 
pathway [53]. Leptin, on the other hand, is involved 
in the control of bone mass by a complex mechanism 
that has an important role in the central nervous system 
(CNS) and osteoblastic b2-adrenergic receptors [55, 56]. 
Our studies in girls with AN revealed a positive and 
significant correlation between changes in adiponectin 
concentrations and OPG, and a negative correlation 
between changes in adiponectin concentrations and 
the OPG/sRANKL ratio. On the other hand, the OPG/ 
/sRANKL ratio was positively and significantly cor-
related with changes in leptin levels. Adiponectin was 
found to be an independent predictor of OPG, while 
adiponectin and leptin turned out to be independent 
predictors of the OPG/sRANKL ratio [26]. It has been 
suggested that vaspin might also modify the actions 
of pro-inflammatory cytokines, including TNF-a, IL-6, 
or IL-1 [32, 57, 58]. Vaspin attenuates inflammatory 
cytokine-induced nuclear factor-kB (NF-kB) activation 
via the activation of AMP-activated protein kinase 
(AMPK) in vascular endothelial cells [57]. Liu et al.’s 
[58] studies showed that vaspin inhibited TNF-a and 
IL-1-mediated activation of NF-kB and its downstream 
molecules in a concentration-dependent manner. Hence 
it could be speculated that vaspin might also modify 
the effects of pro-inflammatory cytokine actions in 
bone tissue. In girls with AN, we found positive and 
significant correlations between changes in IL-1b, IL-6 
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concentrations, and CTx as well as between changes 
in TNF-a levels and sRANKL, while the correlation 
between changes in TNF-a concentrations and the OPG/ 
/sRANKL ratio was negative. IL-6 and IL-1b were shown 
to be independent predictors of CTx; TNF-a and IL-6 
turned out to be independent predictors of sRANKL, 
while TNF-a, IL-6, and IL-1b were independent predic-
tors of the OPG/sRANKL ratio [59]. 
As already mentioned, GH and thyroid hormones 
might affect vaspin secretion and act as regulators of 
bone metabolism. In patients with AN, a significant 
age-related correlation was found between GH, free 
T4, and free T3 and markers of bone formation and 
resorption [39, 40, 43]. IGF-I and free T3 were shown 
to be independent predictors of CTx in girls with AN 
while GH was an independent predictor of OC in both 
girls and women with AN [43]. Our studies on girls 
with AN revealed that free T3 was an independent 
predictor of sRANKL and the OPG/sRANKL ratio [52]. 
It has been suggested that GH resistance and changes 
in the hypothalamic-pituitary-thyroid axis may play 
a role in the osteopaenia and decreased peak bone mass 
frequently associated with AN [39–41]. On this basis it 
could be speculated that changes in GH and thyroid 
hormone concentrations observed in patients with AN 
might affect vaspin concentrations and hence modulate 
bone remodelling.
To sum up: undernourishment and associated deficit 
of adipose tissue may result in inadequate serum vaspin 
concentrations and bone metabolism disturbances in 
girls with AN. A relationship found between vaspin 
and soluble ligand sRANKL, and the OPG/sRANKL 
ratio, indicates that vaspin might regulate the dynamic 
balance between bone formation and resorption pro-
cesses through the cytokines of the RANKL/RANK/ 
/OPG system. However, it cannot be ruled out that the 
relationship might involve some osteotropic agents, 
mainly hormones and cytokines (whose concentra-
tions are abnormal in AN and which modulate or are 
modulated by vaspin). Changes in the relationships 
between vaspin, the above-mentioned osteotropic 
agents, bone markers, and cytokines of the RANKL/ 
/RANK/OPG system might underlie the development 
of osteoporosis in girls with AN.
Conclusions
Undernourishment and associated deficit of adipose 
tissue may cause inadequate vaspin production and 
bone metabolism disturbances in girls with AN. 
Vaspin acts as a coordinator of the dynamic balance 
between bone formation and resorption processes; its 
action is affected by the cytokines of the RANKL/RANK/ 
/OPG system.
Changes in the relationships between vaspin, bone 
markers, OPG, and RANKL might be involved in the 
development of osteoporosis in girls with AN.
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